🔴 Moderna is trading 4.04% down today in a post-rally pullback

Moderna is trading 4.04% down at $215.91 on October 12, in a pullback following Friday’s sharp rally.

• No fresh company-specific announcement explaining the decline surfaced in available coverage.
• Friday’s rally was linked to Nasdaq-100 inclusion and renewed cancer-vaccine interest; recent commentary also described profit-taking after a steep run.
• The broader market is mixed and not moving down enough to clearly explain the decline; coverage also points to valuation concerns and a prior broad biotech sell-off.